Monthly Archives: November 2017
Exam 2: A Life-Threatening Cause of Colitis
Signature Celebration of Gastroenterology, Colorectal Cancer
Gastroenterology has published many seminal articles that have transformed our understanding of colorectal cancer (CRC) as well as being influential in promoting colorectal cancer screening which has saved many people from developing the disease. CRC h… Continue reading
Alcohol Abuse and Liver Disease
Since ancient Grecian times, alcohol has been known to cause liver disease. Yet, well into the Modern Age, the United States, China, Nigeria, and other countries throughout the world continue to witness an increase in alcohol consumption and associated… Continue reading
Computed Tomography Colonography vs Colonoscopy for Colorectal Cancer Surveillance After Surgery
Recommendations for surveillance after curative surgery for colorectal cancer (CRC) include a 1 year post-resection abdominal-pelvic computed tomography scan and optical colonoscopy (OC). CT colonography (CTC), when used in CRC screening, effectively i… Continue reading
Factors Associated with Response to Teduglutide in Patients With Short-bowel Syndrome and Intestinal Failure
Clinical studies showed teduglutide to increase urine production and reduce need for parenteral support volume in patients with short bowel syndrome (SBS) with intestinal failure, increasing intestinal wet weight absorption and reducing diarrhea. Howev… Continue reading
Efficacy of Indigo naturalis in a Multicenter Randomized Controlled Trial of Patients with Ulcerative Colitis
Indigo naturalis (IN) is a traditional Chinese medicine that contains ligands for the aryl hydrocarbon receptor and promotes regeneration of the mucosa, by inducing production of interleukin 22. IN might induce mucosal healing in patients with ulcerati… Continue reading
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected with HBV
There have been reports of reactivation of hepatitis B virus (HBV) infection during treatment of hepatitis C virus (HCV) infection with direct-acting antiviral agents. We performed a prospective study of risks and outcomes of HCV infection treatment wi… Continue reading